@article{karoui:hal-03595517,
TITLE = {Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high-risk Stage II and III colon cancers? Three years' follow-up results of the PRODIGE 22 phase II randomized multicentre trial},
AUTHOR = {Karoui, Mehdi and Gallois, Claire and Piessen, Guillaume and Legoux, Jean-Louis and Barbier, Emilie and de Chaisemartin, Cecile and Lecaille, Cedric and Bouche, Olivier and Ammarguellat, Hanifa and Brunetti, Francesco and Prudhomme, Michel and Regimbeau, Jean-Marc and Glehen, Olivier and Lievre, Astrid and Portier, Guillaume and Hartwig, Johannes and Goujon, Gael and Romain, Benoit and Lepage, Come and Taieb, Julien},
URL = {https://u-picardie.hal.science/hal-03595517},
JOURNAL = {Colorectal Disease},
PUBLISHER = {Wiley},
VOLUME = {23},
NUMBER = {6},
PAGES = {1357-1369},
YEAR = {2021},
MONTH = Jun, DOI = {10.1111/codi.15585},
KEYWORDS = {colectomy ; colon cancer ; neoadjuvant chemotherapy ; survival},
HAL_ID = {hal-03595517},
HAL_VERSION = {v1},
}